Align Technology, Inc. ALGN
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Align Technology, Inc. (ALGN) Price to free cash flow
As of 25 September 2026, Align Technology, Inc. (ALGN) trades at a price to free cash flow of 15.5×. Over the past ten years it has ranged from 14.3× (September 2025) to 132× (October 2018); the current reading is higher than 1% of that period. That is below the Medical Instruments & Supplies industry median of 25.7× and below the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 23.1× | (7.95%) |
| FY2024 | 25.1× | (25.82%) |
| FY2023 | 33.8× | (43.63%) |
| FY2022 | 60.0× | (10.81%) |
| FY2021 | 67.2× | (18.97%) |
| FY2020 | 83.0× | 123.71% |
| FY2019 | 37.1× | (26.71%) |
| FY2018 | 50.6× | (31.69%) |
| FY2017 | 74.1× | 69.41% |
| FY2016 | 43.7× | 53.18% |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 17.8× | (14.92%) |
| Mar 2026 | 21.0× | (9.11%) |
| Dec 2025 | 23.1× | 44.30% |
| Sep 2025 | 16.0× | (26.48%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | n/m |
| SOLV Solventum Corporation compare | n/m |
| BAX Baxter International Inc. compare | 14.8× |
| ALGN Align Technology, Inc. | 15.5× |
| COO The Cooper Companies, Inc. compare | 15.8× |
| AVTR Avantor, Inc. compare | 22.7× |
| ATR AptarGroup, Inc. compare | 25.1× |
| BLCO Bausch + Lomb Corporation compare | 53.9× |
| RGEN Repligen Corporation compare | 175× |
| Medical Instruments & Supplies industry median | 25.7× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement